SNDX DEF 14A DEF-14A Report April 1, 2025 | Alphaminr
Syndax Pharmaceuticals Inc

SNDX DEF 14A Report ended April 1, 2025

SYNDAX PHARMACEUTICALS INC
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
CIK: 1395937
Filing Type: DEFA14A
Report Date: 2025-04-01
Download URL: https://www.sec.gov/Archives/edgar/data/1395937/000095017025048476/sndx-20250401.htm
]]>
TABLE OF CONTENTS
GENERAL INFORMATIONPROPOSAL 1 ELECTION OF DIRECTORSGeneralVote RequiredOur RecommendationInformation About Our Board of DirectorsINFORMATION ABOUT OUR BOARD OF DIRECTORSEXECUTIVE OFFICERSTHE BOARD OF DIRECTORS AND ITS COMMITTEESBoard IndependenceBoard Meetings and AttendanceBoard CommitteesCompensation Committee Interlocks and Insider ParticipationLeadership Structure and Risk OversightCode of Business Conduct and EthicsStockholder Communications with Our Board of DirectorsPROPOSAL 2 ADVISORY VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERSPROPOSAL 3 RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMPre-Approval Policies and ProceduresIndependent Registered Public Accounting Firm FeesOur RecommendationCOMPENSATION DISCUSSION AND ANALYSISCompany OverviewLeadership TransitionExecutive Compensation Philosophy and ObjectivesPay Program OverviewCEO and Other NEO Pay MixCompensation Program GovernanceCompensation Determination ProcessComponents of Our Executive Compensation ProgramAdditional Compensation Policies and PracticesReport of Compensation Committee on Executive CompensationEXECUTIVE OFFICER AND DIRECTOR COMPENSATIONExecutive Officer CompensationOutstanding Equity Awards at Fiscal Year-EndOption Exercises and Stock-VestedEquity PlansEmployment Agreements with Named Executive OfficersPotential Payments Upon Termination or Change in ControlPay Ratio DisclosureDirector CompensationLimitation on Liability and IndemnificationRule 10b5-1 Sales PlansPAY VERSUS PERFORMANCERelationship Between PEO and Non-PEO NEO CAP, Company TSR and Peer Group TSRRelationship Between PEO and Non-PEO NEO CAP and Net IncomeRelationship Between PEO and Non-PEO NEO CAP and Stock PriceCERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONSPolicies and Procedures Regarding Transactions with Related PartiesCertain Related-Party TransactionsSECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERSSecurity Ownership of Certain Beneficial Owners and ManagementSecurities Authorized for Issuance Under Equity Compensation Plans